Loss of quinidine gluconate injection in a polyvinyl chloride infusion system

American Journal of Health-System Pharmacy

Volumn 53, Issue 6, 1996, Pages 655-658

  Darbar, Dawood ^a   Dell'Orto, Simonetta ^a   Wilkinson, Grant R ^a   Roden, Dan M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Absorption; Additives; Adsorption; Blood levels; Cardiac drugs; Concentration; Containers; Dextrose; Diethylhexyl phthalate; Diluents; Drug administration routes; Drugs, availability; Incompatibilities; Injections; Leaching; Pharmacokinetics; Photodeco mposition; Polyvinyl chloride; Quinidine gluconate; Quinidine sulfate; Stability; Surgical supplies; Tubing

Indexed keywords

POLYVINYLCHLORIDE; QUINIDINE GLUCONATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG STABILITY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

EID: 0029947208     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.6.655     Document Type: Article

References (21)

1. Harrison DC, Meffin PJ, Winkle RA. Clinical pharmacokinetics of antiarrhythmic drugs Prog Cardiovasc Dis. 1977; 20:217-42.
2. Guentert TW, Holford NHG, Coates PE et al. Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies. J Pharmacokinet Biopharm. 1979; 7:315-30
3. Ueda CT, Dzindzio BS. Quinidine kinetics in congestive heart failure. Clin Pharmacol Ther. 1978; 23:158-64.
4. Mason DT. Antiarrhythmic agents: mechanism of action, clinical pharmacology and therapeutic considerations. In: Graeme SA, ed. Cardiovascular drugs. Vol. 1 Baltimore: University Park Press, 1978:75-127.
5. Drayer DE, Lowenthal DT, Restivo KM et al. Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function. Clin Pharmacol Ther. 1978; 34:31-9.
6. Morris ME. Compatibility and stability of diazepam injection following dilution with intravenous fluids. Am J Hosp Pharm. 1978; 35:669-72.
7. Chiou WL, Moorhatch P. Interaction between vitamin A and plastic intravenous fluid bags. JAMA. 1973; 223:328. Letter.
8. Hirsch JJ, Fratkin MJ, Wook JH et al. Clinical significance of insulin adsorption by polyvinyl chloride infusion systems. Am J Hosp Pharm. 1977; 34:583-8.
9. Baaske DM, Amann AH, Wagenknecht DM et al. Nitroglycerin compatibility with intravenous fluid filters, containers, and administration sets. Am J Hosp Pharm. 1980; 37:201-5.
10. Thompson KA, Blair IA, Woosley RL et al. Comparative in vitro electrophysiology of quinidine, its major metabolites and dihydroquinidine. J Pharmacol Exp Ther. 1987; 241:84-90.
11. Kates RE, McKennon DW, Comstock TJ. Rapid high-pressure liquid Chromatographic determination of quinidine and dihydroquinidine in plasma samples. J Pharm Sci. 1978; 67:269-70.
12. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Dekker; 1982:409-16.
13. Ueda CT, Williamson BJ, Dzindzio BS. Absolute quinidine bioavailability. Clin Pharmacol Ther. 1976; 20:260-5.
14. Greenblatt DJ. Pfeifer HJ, Ochs HR et al. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration. J Clin Pharmacol. 1977; 202:365-78.
15. Jaeger RJ, Rubin RJ. Migration of a phthalate ester plasticizer from polyvinyl chloride blood bags into stored human blood and its localization in human tissues. N Engl J Med. 1972; 287:1114-8.
16. Ditlefen EML. Concentrations of quinidine in blood following oral, parenteral and rectal administration. Acta Med Scand. 1953; 146:81-92.
17. Yount EH, Rosenblum M. Studies of plasma quinidine levels in relation to therapeutic effect and toxic manifestations. South Med J. 1950: 43.324-8.
18. Graham PR. Phthatate ester plasticizers: why and how they are used. Environ Health Perspect. 1973; 3:3-12.
19. Moorhatch P, Chiou WL. Interactions between drugs and plastic intravenous fluid bags. Part ii: leaching of chemicals from bags containing various solvent media. Am J Hosp Pharm. 1974; 31:149-52.
20. Corley JH, Needham TE, Sumner ED et al. Effect of various factors on the amount of plasticizer in intravenous solutions packaged in various bags. Am J Hosp Pharm. 1977; 34:259-64.
21. Waugh WN, Trissel LA, Stella VJ. Stability, compatibility and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. Am J Hosp Pharm. 1991; 48:1520-4.